VGX PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 10245
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 6161
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 4103
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
C07K PEPTIDES 2134
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9592285 Vaccines against multiple subtypes of influenza virusNov 12, 08Mar 14, 17[A61K, C07K]
9452285 Electroporation devices and methods of using same for electroporation of cells in mammalsOct 17, 07Sep 27, 16[A61N]
8962818 Compositions comprising GHRH and GnRH and methods of using the sameMar 06, 09Feb 24, 15[A61K]
8927508 Antibody production elicited by a DNA vaccine delivered by electroporationNov 14, 08Jan 06, 15[A61K, C12N]
8835620 Vaccines against multiple subtypes of dengue virusJan 12, 09Sep 16, 14[C07H, A61K, C07K]
8563302 Optimized high yield synthetic plasmidsNov 17, 10Oct 22, 13[C07H, C12N]
8481504 Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applicationsMar 11, 04Jul 09, 13[A61K, A01N]
8209006 Constant current electroporation device and methods of useSep 08, 03Jun 26, 12[A61N]
8188056 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementationDec 17, 04May 29, 12[A61K, C61K, C12N, A61P]
8178504 Gene therapy expression of GHRH for increasing RBC count in subjectsMar 21, 07May 15, 12[A61K, A01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2009/0292,107 COMPOSITION AND METHOD TO ALTER LEAN BODY MASS AND BONE PROPERTIES IN A SUBJECTAbandonedJan 23, 08Nov 26, 09[C07K]
2009/0074,721 METHODS FOR TREATING VIRAL INFECTION WITH ORAL OR INJECTIBEL DRUG SOLUTIONAbandonedJun 06, 06Mar 19, 09[A61K, A61P]
2009/0005,333 REDUCING CULLING IN HERD ANIMALS GROWTH HORMONE RELEASING HORMONE (GHRH)AbandonedMar 07, 08Jan 01, 09[A61K, A61P]
2008/0221,034 CANINE SPECIFIC GROWTH HORMONE RELEASING HORMONEAbandonedApr 03, 08Sep 11, 08[A61K, C07H, A61P, C07K]
2008/0207,543 MODIFIED PITUITARY GLAND DEVELOPMENT IN OFFSPRING FROM EXPECTANT MOTHER ANIMALS TREATED WITH GROWTH HORMONE RELEASING HORMONE THERAPYAbandonedJul 09, 07Aug 28, 08[A61K, C12N, A61P]
2008/0194,511 CODON OPTIMIZED SYNTHETIC PLASMIDSAbandonedNov 16, 07Aug 14, 08[A61K]
2007/0259,014 Compositions for and Methods for Treating HivAbandonedJun 21, 04Nov 08, 07[A61K, A61P]
2007/0259,844 Antiviral Compositions And Methods Of Using The SameAbandonedJun 21, 04Nov 08, 07[A61K]
2006/0025,368 Growth hormone releasing hormone enhances vaccination responseAbandonedJul 21, 05Feb 02, 06[A61K, C12N]
2005/0004,060 Plasmid mediated GHRH supplementation for renal failuresAbandonedApr 20, 04Jan 06, 05[A61K]
2004/0204,358 Reducing culling in herd animals growth hormone releasing hormone (GHRH)AbandonedJan 26, 04Oct 14, 04[A61K]
2004/0175,727 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cellsAbandonedOct 30, 03Sep 09, 04[C12Q, C12N, G01N]
2004/0014,645 Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") systemAbandonedMar 24, 03Jan 22, 04[A61K, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.